英国和欧洲专利律师 | 特许商标律师

保护创意和资产

法律服务

专利、商标和外观设计

我们帮助各种形式和规模的个人和企业

施利希是一个独特的欧洲专利和商标律师团队，总部位于英格兰南部。自2004年以来，我们帮助客户收购和保护他们的知识产权资产，帮助他们在知识产权资产的基础上建立和发展成功的企业。

我们起草和提交专利申请，使其获得批准并实施强制执行。我们还准备和提交商标申请，并为其注册进行起诉。

T为了执行客户的权利，我们还代表他们参加法院和其他各方之间的诉讼程序（必要时，提出异议和撤销竞争对手的权利）。

查看知识产权服务

近期案例解析

阅读施利希团队关于涉及专利、商标和外观设计的近期真实案例解析和新闻动态。

查看所有案例解析

A not so rosy decision for L’Oréal

In a recent judgement, the Board of Appeal of the European Union Intellectual Property Office (EUIPO) dealt with a trade mark dispute between well-known cosmetics manufacturer L'Oréal and Chinese rival Guangzhou Ya Ti Ao Jia Cosmetics Co., Ltd ‘Guangzhou’ regarding L'Oréal’s figurative rose mark associated with the Lancôme brand.

UPC Court of Appeal Shifts Focus to Germany

We recently reported on the UPC’s decision to hear the Nokia v Mala case, regardless of parallel German proceedings pending for the same patent. Interestingly, the UPC Court of Appeal has reacted quickly with a different view. This update is reported here.

Your Court or Mine? UPC takes home advantage

Nokia filed two separate revocation actions challenging Mala’s EP 2 044 709 patent, valid only in Germany. The first was filed on 29 April 2021 in the German Federal Patent Court but was unsuccessful, as the patent was upheld (appeal pending). The second was filed on 15 December 2023 in the Unified Patent Court (UPC). This article focuses on Mala’s objection to the UPC's jurisdiction, in which they argued that since a revocation action was already ongoing in Germany, the UPC should reject Nokia’s action as inadmissible.

The Federal Circuit clarifies conflicts arising between Patent Term Adjustment and Obviousness-type Double Patenting

We perceive a sigh of relief from some patent holders following issue of the US Federal Circuit’s decision in Allergan USA v. MSN Labs, 24-1061 (Fed. Cir. August 13, 2014) (“Allergan”). This decision appears to forestall the revocation of some patents following the concerning precedential Federal Circuit decision In re Cellect (No. 22-1293) (“Cellect”).

Directors Off the Hook: Supreme Court Rules No Personal Liability in Lifestyle Equities CV v Ahmed

Does the recent UK Supreme Court provide company directors with a ‘Get out of jail free card’ for personal liability?

What Satisfies the Palate of the EPO’s Boards of Appeal? Fish Oil and Fruit Juice, Apparently…

In a recent decision, the EPO’s Boards of Appeal have confirmed the importance of filing data to support arguments relating to sufficiency of disclosure in EPO opposition proceedings. The patent concerned related to a mixture of fish oil and fruit juice which was alleged to have anticancer properties. The opponent argued the constituents required to achieve the anticancer effect were not sufficiently disclosed, but failed to provide enough data to convince the Board of Appeal. Hence, the Board was satisfied the claimed composition was sufficiently disclosed and ordered that the patent be maintained in amended form.

Scientific beakers filled with coloured liquid

Boards of Appeal Introduce New Broad Interpretation of “Substance or Composition” in the Context of Second Medical Use Claims

In this decision the Board has diverged from previous case law establishing that second medical use claims were restricted to products having a chemical mode of action and instead the Board ruled that “substance or composition” should stretch to any product which may be defined by its chemical composition, regardless of the mode of action.

First Revocation Decision of the UPC Confirms the European Approach to Antibody Inventions

This case represents the first revocation issued by the UPC and so gives several useful insights into the way in which the court will apply the law.

在专利和商标法方面的卓越表现

施利希团队

由于施利希经验丰富的专业团队，我们的客户获得了超越期望值的迅速回馈，高质量和高价值的友好服务。我们的英国和欧洲专利律师以及特许商标律师，拥有英国顶尖大学的广泛科学和技术专业学位和博士学位，并在法律和商业问题及技术的最前沿拥有几十年的咨询经验。

我们在起诉和跨部门诉讼方面积累了深厚的经验，为客户的创新成果提供最佳的战略和实践建议，并确保最佳的专利和商标保护。我们的团队在更多高技能和经验丰富的法律支持人员团队的支持下，以友好和明确的方式高效地完成了每项诉讼事务。

更多关于我们团队的信息